Why This 1 Cannabis Stock Sticks Out Like a Sore Thumb

Looking for growth in a choppy market? Find out now why Green Thumb Industries (CNSX:GTII) isn’t like other cannabis stocks.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It was popular for a while to refer to the cannabis space as another dot-com bubble. There were definitely similarities: a new industry full of potential was getting investors exciting, driving up share prices until the bubble burst. Post-legalization, many of the great green hopes touted by early cannabis bulls were up in smoke, to use a tired idiom. But cannabis still has a market and a tangible commodity.

But does it still have upside? After all, cannabis is a plant that can be grown anywhere and by anyone. In a moment we’re going to take a quick look at a stock that has been garnering some positive press. Its success in 2020 challenges the idea that legal cannabis is drained of momentum.

A pot stock that bucks the trend

Growth investors looking to pump funds into cannabis have a clear winner in Green Thumb Industries (CNSX:GTII). This name just reported Q2 revenue growth of almost 17%. This is pretty remarkable given an exceptionally flat cannabis market oversaturated by too many players. Paying attention to which cannabis names the markets like can pay off for the bold pot stock investor, and this name impresses.

But investors should ask themselves just how sustainable upside might be in a space already dominated by a well-established black market. Beset by a hamstrung retail environment and undermined by the pandemic, the case for cannabis upside has been growing steadily weaker.

Cannabis investors seeking some resilient upside in a frothy broader market may want to stack shares in Green Thumb this summer. This name has seen its share price climb 31% in the past month. Looking back a little further, cannabis investors have pushed this name up more than 50% since mid-June. This is the kind of share price performance that cannabis investors ideally should have seen ever since post-legalization.

Sticking out like a Green Thumb

Investors who have been keeping an eye on cannabis performance are no doubt aware of Green Thumb’s momentum. But the key is to pinpoint whether this is sustainable. A recovery is likely to see cannabis sales bounce back, while an overhauled retail space could also turn its fortunes around.

Green Thumb really sticks out in an industry that has seen one big name disappoint after another. Look at the performance of some of the brightest hopes in the cannabis space. Up 70.3% in 12 months, Green Thumb stock has been more popular than most. Compare that with HEXO’s 82.9% year-on-year decline.

Despite this, future cash flows are projected to be so strong that Green Thumb’s current price is about 80% below fair value. Couple that with the potential for annual earnings growth of around 77% in the next couple of years, and you have the beginnings of a buy thesis.

Green Thumb’s price is relatively attractive at around 3.7 times book. The bottom line for cannabis stock investors, though, has to be that 16.6% sequential Q2 revenue growth. Matched with a potential total one-year return of 72%, this is a highly responsive stock that is impressing investors and generating some strong positive momentum.

Should you invest $1,000 in Green Thumb Industries right now?

Before you buy stock in Green Thumb Industries, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Green Thumb Industries wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »